Holen Sie sich die Stockscreener-App
85.82
2.08%
-1.82
Schlusskurs vom Vortag:
$87.64
Offen:
$87.44
24-Stunden-Volumen:
106.81K
Relative Volume:
1.23
Marktkapitalisierung:
$1.10B
Einnahmen:
$86.28M
Nettoeinkommen (Verlust:
$23.61M
KGV:
46.75
EPS:
1.8359
Netto-Cashflow:
$23.97M
1W Leistung:
-2.78%
1M Leistung:
-0.61%
6M Leistung:
-3.36%
1J Leistung:
+10.10%
1-Tages-Spanne:
$85.46
$87.90
1-Wochen-Bereich:
$85.46
$89.48
52-Wochen-Spanne:
$75.75
$107.90
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Compare IRMD vs ABT, MDT, SYK, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
85.82 | 1.10B | 86.28M | 23.61M | 23.97M | 1.8359 |
ABT
Abbott Laboratories
|
103.70 | 179.44B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
95.41 | 122.04B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
307.15 | 117.81B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
45.69 | 66.22B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.07 | 51.34B | 6.30B | 1.07B | 1.09B | 1.8406 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-09-22 | Eingeleitet | Needham | Hold |
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
(IRMD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
iRadimed (IRMD) Rises 1.83% to $87.45, Sitting Midway Between Support and ResistanceCovered Call ETF - https://www.siam.in/
iRadimed Corporation (IRMD) Ticks Higher as Shares Test Upper Trading RangeRelative Volume - https://www.siam.in/
(IRMD) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
IRadimed Director Joe Kiani Acquires 698 Shares Through RSU Vesting on September 23, 2026 - Kalkine Media
698 stock units became shares for IRADIMED (NASDAQ: IRMD) director Joe E. Kiani. - Stock Titan
Form 4 Iradimed Co For: 25 September By Investing.com - Investing.com UK
One-on-one investor meetings with Iradimed's CFO are set for New York - Stock Titan
IRADIMED Insiders Sell US$3.4m Of Stock, Possibly Signalling Caution - Moomoo
Needham initiates IRadimed stock with Hold on valuation concerns By Investing.com - Investing.com Australia
Needham Initiates IRadimed at Hold - marketscreener.com
Needham initiates IRadimed stock with Hold on valuation concerns - Investing.com
(IRMD) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Iradimed Stock Price Forecast. Should You Buy IRMD? - StockInvest.us
iRadimed Corporation (IRMD) Stock Analysis: Exploring a 42% Upside Potential for Investors - DirectorsTalk Interviews
Is IRADIMED (IRMD) Overvalued After A 157% Five Year Run? - webull.com
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Australia
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com Nigeria
Iradimed director Monty Allen sells $122,621 in stock - Investing.com
Iradimed director Monty Allen sells $122,621 in stock - Investing.com India
Iradimed director Monty Allen sells $122,621 in stock - Investing.com
Director at IRADIMED (IRMD) sells 1,419 shares - stocktitan.net
Iradimed director Monty Allen sells $122,621 in stock By Investing.com - Investing.com South Africa
iRadimed Corp (IRMD) Stock Down 3.8% but Still Overvalued -- GF Score: 92/100 - GuruFocus
IRADIMED (NASDAQ: IRMD) director flags 1,102 RSU shares for possible sale - stocktitan.net
Price to book forward of IRadimed Corp. – TRADEGATE:46K - TradingView
Rice Hall James & Associates LLC Invests $2.91 Million in iRadimed Corporation $IRMD - MarketBeat
Form 8K Iradimed Co For: 18 August By Investing.com - Investing.com UK
iRadimed (NASDAQ:IRMD) Shares Cross Below 200 Day Moving AverageTime to Sell? - MarketBeat
IRMD Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
iRadimed Corporation (NASDAQ:IRMD) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - webull.com
IRADIMED CORPORATION (NASDAQ:IRMD) Looks Interesting, And It's About To Pay A Dividend - Simply Wall Street
iRadimed (NASDAQ:IRMD) Cut to "Hold" at Wall Street Zen - MarketBeat
IRadimed (IRMD) Q2 2026 Earnings Call Transcript - AOL.com
How IRADIMED's Modest Q2 Beat and Reaffirmed 2026 Guidance Will Impact IRMD Investors - Yahoo Finance
Replacement Cycle Anchors IRadimed Corp.’s (IRMD) Long Term Growth - Yahoo Finance
iRadimed Q2 2026 Earnings: EPS Beat Highlights Resilience in MRI-Safe Medical Device NicheEarnings Call Transcript - careplusvn.com
Reaffirmed 2026 Guidance and Dividend Policy Could Be A Game Changer For IRADIMED (IRMD) - simplywall.st
iRadimed (IRMD) Eases 0.74% as Shares Hold Within Established Trading RangeWyckoff Spring - careplusvn.com
IRadimed Corp Earnings Call Highlights Ramp, Resilience - TipRanks
iRadimed (IRMD) Gains 1.71% as Shares Hold Above SupportTriple Bottom - dars.gov.et
iRadimed (IRMD) Gains 1.71% as Price Holds Above Key SupportSupport Level Bounce - dars.gov.et
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... By GuruFocus - Investing.com Canada
iRadimed Corp (IRMD) (Q2 2026) Earnings Call Highlights: Strong Demand for New 3,870 Pump ... - Yahoo Finance
IRADIMED (IRMD) Stock Drops As 3870 Ramp Cuts Gross Margin - Sahm
IRadimed (NASDAQ:IRMD) Medical Devices Update Gains Market Attention Today - Kalkine Media
IRadimed Corporation Q2 2026 Earnings Call Summary - Yahoo Finance
IRadimed Corp reports results for the quarter ended June 30Earnings Summary - tradingview.com
Earnings call transcript: IRadimed tops Q2 2026 estimates as 3870 ramp weighs margins - Investing.com
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Iradimed Corp-Aktie (IRMD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Monty K. Allen | Director |
Sep 03 '26 |
Proposed Sale |
86.42 |
1,419 |
122,624 |
0 |
| Scharen-Guivel Hilda Frederiqu | Director |
Jun 04 '26 |
Sale |
95.00 |
3,000 |
285,000 |
5,598 |
| Hilda Scharen-Guivel | Director |
Jun 04 '26 |
Proposed Sale |
95.00 |
3,000 |
285,000 |
0 |
| Susi Roger E. | CEO, President, Chairman |
Jun 01 '26 |
Sale |
90.60 |
2,500 |
226,507 |
2,162,500 |
| Susi Roger E. | CEO, President, Chairman |
May 27 '26 |
Sale |
91.95 |
2,500 |
229,878 |
2,165,000 |
| Susi Roger E. | CEO, President, Chairman |
May 26 '26 |
Sale |
92.23 |
5,000 |
461,166 |
2,167,500 |
| Susi Roger E. | CEO, President, Chairman |
May 19 '26 |
Sale |
87.88 |
2,500 |
219,694 |
2,172,500 |
| Susi Roger E. | CEO, President, Chairman |
May 18 '26 |
Sale |
87.51 |
5,000 |
437,571 |
2,175,000 |
| Susi Roger E. | CEO, President, Chairman |
May 12 '26 |
Sale |
83.92 |
4,411 |
370,183 |
2,180,000 |
| Susi Roger E. | CEO, President, Chairman |
May 11 '26 |
Sale |
84.54 |
3,089 |
261,157 |
2,184,411 |
7.07%
2.80%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):